Literature DB >> 15537513

Vascular factors in dementia: an overview.

Charles Decarli1.   

Abstract

Alzheimer's disease and cerebrovascular disease are two illnesses common to the elderly. Conventional wisdom has sought to separately describe and treat these two diseases. Accumulating evidence, however, shows that cerebrovascular risk factors may cause asymptomatic brain injury, share genetic risk with Alzheimer's disease and possibly accelerate the Alzheimer's process. Such evidence suggests that these two diseases may act additively or synergistically to cause clinical dementia. This review focuses on evolving data that support this hypothesis.

Entities:  

Mesh:

Year:  2004        PMID: 15537513     DOI: 10.1016/j.jns.2004.09.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

Review 2.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

3.  Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.

Authors:  I Masse; R Bordet; D Deplanque; A Al Khedr; F Richard; C Libersa; F Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.

Authors:  Ali Ezzati; Cuiling Wang; Richard B Lipton; Dorothea Altschul; Mindy J Katz; Dennis W Dickson; Carol A Derby
Journal:  J Am Geriatr Soc       Date:  2017-04-13       Impact factor: 5.562

5.  Localized measures of callosal atrophy are associated with late-life hypertension: AGES-Reykjavik Study.

Authors:  Peter Harris; Dan A Alcantara; Nina Amenta; Oscar L Lopez; Gudný Eiríksdóttir; Sigurdur Sigurdsson; Villmundur Gudnason; Sarah Madsen; Paul M Thompson; Lenore J Launer; Owen T Carmichael
Journal:  Neuroimage       Date:  2008-07-18       Impact factor: 6.556

6.  Cerebral white matter free water: A sensitive biomarker of cognition and function.

Authors:  Pauline Maillard; Evan Fletcher; Baljeet Singh; Oliver Martinez; David K Johnson; John M Olichney; Sarah T Farias; Charles DeCarli
Journal:  Neurology       Date:  2019-04-05       Impact factor: 9.910

7.  Neuroimaging of the aging brain: introduction to the special issue of neuropsychology review.

Authors:  Samuel Lockhart; Charles DeCarli; Rosemary Fama
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

Review 8.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

Review 9.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.

Authors:  Zhi He; Yun Liao; Min Zheng; Fan-Dian Zeng; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.